Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Mersana Therapeutics, Inc. (0M4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
4.26000.0000 (0.00%)
At close: 10:06AM CEST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/27/2023
Current
12/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
411.79M548.53M678.02M429.75M311.28M
Enterprise Value
186.20M310.90M487.05M245.57M186.05M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
16.3240.6082.94152.586.52k
Price/Book (mrq)
5.436.194.842.982.84
Enterprise Value/Revenue
7.0121.1787.3957.3291.38
Enterprise Value/EBITDA
-0.93-7.12-8.29-4.79-4.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 310.94%
S&P500 52-Week Change 3-10.33%
52 Week High 38.2000
52 Week Low 32.6600
50-Day Moving Average 35.2414
200-Day Moving Average 35.9938

Share Statistics

Avg Vol (3 month) 379
Avg Vol (10 day) 3N/A
Shares Outstanding 5108.03M
Implied Shares Outstanding 6N/A
Float 881.23M
% Held by Insiders 11.23%
% Held by Institutions 199.25%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Dec 31, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-766.59%

Management Effectiveness

Return on Assets (ttm)-47.13%
Return on Equity (ttm)-191.03%

Income Statement

Revenue (ttm)26.58M
Revenue Per Share (ttm)0.28
Quarterly Revenue Growth (yoy)133,427.29%
Gross Profit (ttm)-146.8M
EBITDA -202.84M
Net Income Avi to Common (ttm)-204.21M
Diluted EPS (ttm)-2.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)280.71M
Total Cash Per Share (mrq)2.6
Total Debt (mrq)36.74M
Total Debt/Equity (mrq)39.92
Current Ratio (mrq)3.49
Book Value Per Share (mrq)0.88

Cash Flow Statement

Operating Cash Flow (ttm)-49.36M
Levered Free Cash Flow (ttm)-93.22M
Advertisement
Advertisement